Home › Ceres Wins $750K DARPA Grant to Develop Zika, Pathogens Tests

Ceres Wins $750K DARPA Grant to Develop Zika, Pathogens Tests

Feb 22, 2017

NEW YORK (GenomeWeb) – Ceres Nanoscience said today it has received a $750,000 award from the US Department of Defense's Defense Advanced Research Projects Agency (DARPA) to develop the company's Nanotrap technology for detection of Zika and other pathogens.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Featured Webinar

Case Study: 'Companion Informatics' to Automate Immunotherapy Manufacturing and Treatment

Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

What's Popular?

In Molecular Diagnostics

  1. Medicare Covers Adaptive Biotechnologies' ClonoSeq Assay

  2. Liquid Biopsy Panel Expansion Enables Admera Health to Add Immunotherapy Prediction

    Premium

  3. Curetis Subsidiary Ares Ramping Up NGS Antibiotic Resistance Testing Business

    Premium

  4. Minimal Residual Disease Sequencing Poised to Grow Following Lag in Adoption

    Premium

  5. BioFluidica Applying Liquid Biopsy to Detect Leukemia While Reducing Biopsies

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.